ArticleOncoimmunology

C-C motif chemokine 22 predicts postoperative prognosis and adjuvant chemotherapeutic benefits in patients with stage II/III gastric cancer.

Songyang Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.